Skip to content
← Back to this collection

PUBLICATIONS · 19231157

Allele loss at 16q defines poorer prognosis Wilms tumour irrespective of treatment approach in the UKW1-3 clinical trials: a Children's Cancer and Leukaemia Group (CCLG) Study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Eur J Cancer
Publication date
2009 Mar
First author
Messahel B

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Messahel B
      type
      Author
    2. name
      Williams R
      type
      Author
    3. name
      Ridolfi A
      type
      Author
    4. name
      A'hern R
      type
      Author
    5. name
      Warren W
      type
      Author
    6. name
      Tinworth L
      type
      Author
    7. name
      Hobson R
      type
      Author
    8. name
      Al-Saadi R
      type
      Author
    9. name
      Whyman G
      type
      Author
    10. name
      Brundler MA
      type
      Author
    11. name
      Kelsey A
      type
      Author
    12. name
      Sebire N
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Messahel B
      type
      Author
    2. name
      Williams R
      type
      Author
    3. name
      Ridolfi A
      type
      Author
    4. name
      A'hern R
      type
      Author
    5. name
      Warren W
      type
      Author
    6. name
      Tinworth L
      type
      Author
    7. name
      Hobson R
      type
      Author
    8. name
      Al-Saadi R
      type
      Author
    9. name
      Whyman G
      type
      Author
    10. name
      Brundler MA
      type
      Author
    11. name
      Kelsey A
      type
      Author
    12. name
      Sebire N
      type
      Author
    bibliography ids
    1. nci-bib-c3333ac20dd61466da39680f
    book metadata
    content sha256
    5ddd42517d1c8c4d106da610c4e480d8d0769e1395ae0cd119992a1dcad64e60
    document type
    citation
    dois
    1. 10.1016/j.ejca.2009.01.005
    electronic publication date
    display
    2009 Feb 21
    precision
    day
    year
    2009
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:19231157
    immutable id
    pubmed:19231157@5ddd42517d1c8c4d106da610c4e480d8d0769e1395ae0cd119992a1dcad64e60
    journal
    abbreviation
    Eur J Cancer
    issn electronic
    1879-0852
    issn print
    0959-8049
    issue
    5
    name
    European journal of cancer (Oxford, England : 1990)
    nlm unique id
    9005373
    pages
    819-26
    volume
    45
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      19231157
      provenance
      batch id
      27a383f06e5fc3d04fad
      provider
      NCBI PubMed ESummary
      record sha256
      757ffb9e71f6df50ae01289cde5e65ae7a9dd9b62212dbe82cdcf43a00a524f3
      response sha256
      51f0f2a142dbd9b135e872b049b116f51941299445a5416feae10f12fac8d978
      retrieved at
      2026-09-09T23:46:24.265787+00:00
      publication date
      display
      2009 Mar
      precision
      month
      year
      2009
      publication types
      1. Journal Article
      2. Multicenter Study
      3. Randomized Controlled Trial
      4. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/19231157/
      title
      Allele loss at 16q defines poorer prognosis Wilms tumour irrespective of treatment approach in the UKW1-3 clinical trials: a Children's Cancer and Leukaemia Group (CCLG) Study.

      Preserved source evidence · Independent clinical review pending · Not medical advice